Retained Sample Program — Storage Requirements and Retention Periods

Purpose of Retained Samples

Retained, or reserve, samples preserve a representative physical sample from each manufactured batch, held for a defined period after batch manufacture, providing genuine physical material available for future reference should a quality question, complaint investigation, or other need to physically re-examine actual batch material arise after the original batch has already been released and, potentially, largely distributed. This capability serves a genuinely important function distinct from documentation-based investigation alone, since certain investigations genuinely benefit from, or specifically require, access to the actual physical product material rather than relying solely on contemporaneous documentation and test records.

Storage Conditions

Retained samples must be stored under conditions representative of the product's labeled storage requirements, ensuring the retained sample's condition throughout its retention period genuinely represents how properly stored distributed product would also have aged and behaved, rather than storage conditions that might artificially preserve or, conversely, artificially degrade the retained sample relative to genuine distributed product experience. Storage should also protect the retained sample from any handling or environmental exposure not representative of genuine, proper commercial distribution and storage conditions.

Retention Period Rules

Retention period requirements are typically tied to the product's shelf life plus an additional defined period beyond expiry, ensuring retained samples remain available for reference throughout the entire period distributed product could genuinely still be in active use by patients, plus additional time supporting investigation into any quality question potentially arising even shortly after the product's labeled expiry date has passed. Companies should confirm applicable retention period requirements for each specific market the product is distributed in, since requirements can differ somewhat between regulatory jurisdictions, and a globally distributed product's retention program should satisfy the most stringent applicable requirement across all its actual distribution markets.

Sample Quantity Requirements

In the US, 21 CFR 211.170 sets a specific minimum: the reserve sample must consist of at least twice the quantity necessary to perform all the required tests to determine whether the drug product (or, for an active ingredient, whether it) meets its established specifications — not merely enough for a single retest. Sterility and pyrogen testing are excepted from this doubled-quantity requirement, since those tests typically consume the entire available sample or are impractical to double; compressed medical gases are exempt from reserve-sample retention altogether. Facilities should size retained quantity against this “twice the full test panel” standard (or the applicable local equivalent, since requirements are not identical across jurisdictions) rather than a single-retest estimate, and should still plan for the possibility of more than one investigational round consuming part of that reserve before the investigation concludes.

Reference Samples, Retention Samples, and Reference Standards

Within the EU framework (EudraLex Annex 19), “retained sample” actually covers two related but distinct things: a reference sample, kept primarily for further analytical testing (of starting materials, packaging materials, or the finished product), and a retention sample, a fully packaged unit of finished product kept for identification purposes — verifying presentation, packaging, labelling, patient information leaflet, batch number and expiry date. For finished products the two are often the same physical unit and can be treated as interchangeable, but the distinction matters when planning quantity and storage for starting materials, where only a reference sample (not a packaged retention sample) applies. A revised Annex 19, including updated provisions on digital retention samples for parallel-traded products, applies from 24 September 2026 — confirm which version is in force when setting or auditing a program against it. Both are, in turn, distinct from reference standards (discussed in the related reference standard articles), which serve an analytical calibration purpose rather than an investigational or identification one; these categories should never be confused or commingled within laboratory inventory and storage systems.

Access Control and Inventory Management

Retained sample access should be controlled and documented, similar in principle to the reference standard and general sample chain of custody discussed elsewhere in this collection, ensuring any use of retained sample material is properly authorized, documented, and connected to a specific, genuine investigational or quality need, rather than informal, undocumented access that could compromise both the sample's integrity and the program's overall documented traceability and defensibility.

Disposal Following Retention Period Completion

Once a retained sample's required retention period has genuinely concluded, disposal should follow the same documented disposal principles discussed in the related sample management article, confirming appropriate disposal method and formal authorization, ensuring the complete retained sample program maintains a fully documented lifecycle from initial retention through eventual, appropriately authorized disposal.

Program Governance and Periodic Review

A well-governed retained sample program includes periodic review confirming actual retained inventory genuinely matches program requirements across the facility's full current product portfolio, catching any gap, such as a batch missing its required retained sample, before that gap potentially becomes genuinely consequential if a future investigation needs that specific, now-unavailable retained sample material.